Setting the Trend: Gansu Constar Technology Group Redefines Color Contact Lens Aesthetics for the Global Gen Z Market

Setting the Trend: Gansu Constar Technology Group Redefines Color Contact Lens Aesthetics for the Global Gen Z Market

LANZHOU, China – July 3, 2026 – Gansu Constar Technology Group, a premier global pioneer in vision care and soft contact lens manufacturing, today announced the launch of its next-generation color

Read More

AI.cc With Hugging Face to Bring 500+ Open-Source Models to Enterprise API Customers

Strategic integration gives AI.cc enterprise customers immediate API access to Hugging Face’s full open-source model catalog — including Llama 4, Mistral, Falcon, and 500+ community models — through a single

Read More

As Labor Challenges Persist, Agricultural Drones Gain Ground Across U.S. Farms

As U.S. agriculture faces persistent labor shortages and rising operational costs, agricultural drones are becoming an increasingly important tool for improving efficiency and precision. The article explores how companies like

Read More

EssayGrader.ai Rated #1 in Teacher-Rated Review of Best AI Essay Grading Tools for 2026

Independent review by classroom teachers evaluates 6 AI essay grading tools across actual classroom utility, grading accuracy, standards alignment, feedback quality, and time savings. EssayGrader.ai emerges as the most fully

Read More

AI.cc Research: Enterprises Using Multi-Model AI APIs Report 2.4x Higher Customer Satisfaction Scores Than Single-Model Deployments

Study of 1,400 enterprise AI deployments across 19 industries finds multi-model routing delivers measurably superior end-user experience through task-appropriate model selection, faster response times, and 73% lower AI output rejection

Read More

Idiopathic Pulmonary Fibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 70+ key companies continuously working towards developing 75+ Idiopathic Pulmonary Fibrosis treatment therapies, analysis of

Read More

Mesothelioma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | GSK, Merck, Bristol-Myers Squibb, AstraZeneca, Roche, Novartis, Pfizer Inc

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Mesothelioma pipeline constitutes 45+ key companies continuously working towards developing 50+ Mesothelioma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read More

Top Asset Managers in Singapore (2026) Report Published by Metaclade Research

Metaclade Research Publishes Its Latest Research Report Recognizing the Top Asset Managers in Singapore (2026) Metaclade Research has published its latest market research report, “Top Asset Managers in Singapore,” offering

Read More

Scleroderma Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Bayer, Novartis, GSK, Boehringer Ingelheim, Celgene Corp., Johnson & Johnson

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Scleroderma pipeline constitutes 45+ key companies continuously working towards developing 50+ Scleroderma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read More

Spasticity Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Huons, Supernus Pharma, Sun Pharma, Acorda Therapeutics, Merz Pharmaceuticals GmbH

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spasticity pipeline constitutes 10+ key companies continuously working towards developing 12+ Spasticity treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read More